Compare Enveric Biosciences Inc (ENVB) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Global X Uranium ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.80M), while Global X Uranium ETF trades at $38.9 (market cap $5.48B). The key difference: Global X Uranium ETF is far larger — about 805.9× Enveric Biosciences Inc's market cap, and Enveric Biosciences Inc is more actively traded (64,867 versus 5,287,170). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Global X Uranium ETF for 62 Days on average.
| ENVB | URA | |
|---|---|---|
Market Cap | $6.80M | $5.48B |
Volume | 64,867 | 5,287,170 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $10.80 | $61.81 |
52-Week Low | $1.27 | $37.52 |
Typical Hold Time | 14 Days | 62 Days |
Enterprise Value | -$1.49M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.52, up 1.67% with a bearish technical outlook despite recent earnings beats. The biotechnology company shows no revenue but has secured new patent allowances and presented positive preclinical data for its non-hallucinogenic psychiatric candidates. Financials reveal negative profitability metrics with ROE at -235.48% and negative EBITDA of $8.57M, though cash flow improved from financing activities.
Analyst consensus is bullish with 75% buy ratings, but high business execution risks and cash burn pose challenges. Investment opportunity lies in pipeline advancements, while risks include clinical trial outcomes and funding needs. The stock faces technical resistance at $2 with current price near support levels.
URA (Global X Uranium ETF) is trading at $38.56, down 3.43% amid bearish technical signals with 19 sell indicators versus 3 buy signals. The ETF faces pressure despite positive nuclear energy sector news, including government funding commitments and growing AI power demand. Current price sits near key support at $38 with resistance at $39.
The uranium sector shows long-term potential with nuclear energy expansion and AI power needs, but URA faces near-term volatility from commodity price sensitivity and concentrated holdings. Investors should weigh structural supply deficits against technical weakness and sector-specific risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
